Our results propose that PMLIV overexpression inhibits the proliferation of breast cancer cells by concurrently regulating the oncogenic transcription factor FOXM1 and the tumor suppressor FOXO3 that acts upstream of FOXM1. Here, FOXO3 is linked to breast carcinoma.